Company / Operating Income per Share
Akebia Therapeutics, Inc. Operating Income per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.10
FY2025
5-year range
-$1.93 / $0.10
FY2021-FY2025
Trend
+140.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-6.16 in FY2014 to $0.10 in FY2025.
Based on SEC 10-K filings.
0.10 in FY2025.
Improved from $-0.25 to $0.10 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 140.3% year-over-year.
- Lowest operating income per share in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | +140.3% |
| FY2024 | -$0.26 | -3.3% |
| FY2023 | -$0.25 | +45.0% |
| FY2022 | -$0.46 | +76.4% |
| FY2021 | -$1.93 | -32.0% |
| FY2020 | -$1.46 | -123.2% |
| FY2019 | -$0.66 | +77.1% |
| FY2018 | -$2.87 | -266.4% |
| FY2015 | -$0.78 | +87.3% |
| FY2014 | -$6.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026